Previous close | 2.5400 |
Open | 2.6000 |
Bid | 0.1000 |
Ask | 0.8500 |
Strike | 360.00 |
Expiry date | 2024-06-21 |
Day's range | 2.4500 - 2.6000 |
Contract range | N/A |
Volume | |
Open interest | 94 |
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
STERIS' (STE) strong prospects in the healthcare and pharmaceutical industries bode well for investors.
Tenet Healthcare's (THC) Q1 results reflect strength in admissions and improved pricing yield. It expects an adjusted EPS of $8.37-$9.41 for 2024, higher than the earlier mentioned $5.76-$6.90.